Page last updated: 2024-08-23

glucaric acid and Anemia

glucaric acid has been researched along with Anemia in 124 studies

Research

Studies (124)

TimeframeStudies, this research(%)All Research%
pre-199013 (10.48)18.7374
1990's12 (9.68)18.2507
2000's51 (41.13)29.6817
2010's46 (37.10)24.3611
2020's2 (1.61)2.80

Authors

AuthorsStudies
Butragueño-Laiseca, L; de la Mata Navazo, S; Sánchez Galindo, AC; Santiago Lozano, MJ1
Bai, Z; Feng, R; Guo, X; Hong, C; Qi, X; Romeiro, FG; Xu, X; Zhang, D1
Frey, M; Kerrey, BT; Overmann, KM; Richert, A1
Barea-Mendoza, J; Brashears, SL; Cortés-Puch, I; Kim-Shapiro, DB; Klein, HG; Natanson, C; Perlegas, A; Solomon, SB; Suffredini, DA; Sun, J; Xu, W1
Imai, N; Shibagaki, Y; Taki, Y1
Alcântara Rodrigues de Moraes, M; Bueno Garcia, E; Francescato Veiga, D; Masako Ferreira, L; Montano-Pedroso, JC1
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Seidel, L; Servais, S; Vanstraelen, G; Willems, E1
Forward, DP; Moppett, IK; Rowlands, M; Sahota, O1
Abbasi, S; Abdel-Razeq, H; Abdelelah, H; Jaber, R; Saadi, I1
Kalaivani, K1
Agarwal, N; Bhatla, N; Dash, BB; Kriplani, A; Kulshreshta, V; Mahey, R1
Athibovonsuk, P; Manchana, T; Sirisabya, N1
Mekic, M; Musanovic, A; Trnacevic, S1
Berry, S; Burlew, CC; Cappa, A; Holena, DN; Jaouen, B; Jurkovich, J; Maier, R; Moore, EE; Pieracci, FM; Rodil, M; Stovall, RT1
Artz, AS; Barnhart, H; Berger, NA; Chelune, G; Cohen, HJ; Ershler, WB; Gordeuk, VR; Prchal, J; Price, E; Rao, SV; Reuben, D; Roy, CN; Sapp, S; Schrier, SL; Supiano, MA; Walston, JD1
Corwin, HL; Napolitano, LM1
Albinarrate, A; Barrachina, B; López-Ariznabarreta, C; López-Picado, A; Molano, J; Oiartzabal, I1
Kox, M; Pickkers, P; van Eijk, LT1
Pieracci, FM1
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É1
Ang, D; Bavry, AA; Beck, A; Efron, P; Rebel, A1
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC1
Couffignal, C; Driss, F; Dufour, G; Duval, X; Lasocki, S; Lefebvre, T; Piednoir, P; Puy, H; Rineau, E; Schilte, C1
Amato, C; Barbieri, C; Bellocchio, F; Bolzoni, E; Canaud, B; Cattinelli, I; Gatti, E; Macdougall, IC; Mari, F; Martin, JD; Stopper, A; Stuard, S1
Cao, G; Dominici, FP; Giani, JF; Rivas, C; Toblli, JE1
Ferreira, LM; Garcia, EB; Montano-Pedroso, JC; Novo, NF; Veiga, DF1
Kozlovskaya, LV; Markina, MM; Milovanov, YS; Milovanova, SY; Mukhin, NA1
Gemici, C; Mayadagli, A; Ozden, S; Ozyurt, H; Tepetam, H; Yaprak, G; Yetmen, O1
Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A1
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Fishbane, S; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC1
Cuenca, J; García-Erce, JA; Muñoz, M1
Auerbach, M; Ballard, H1
Backe, B; Borthen, I; Kolås, T; Løkvik, B; Nakling, J; Rognerud Jensen, OH; Salvesen, KA; Smedvig, E; Westad, S; Økland, I1
Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N1
Lorch, JA; Pollak, VE; Satwah, S; Shukla, R1
Befrits, R; Blom, H; Eriksson, A; Grännö, C; Hjortswang, H; Lindgren, A; Lindgren, S; Ung, KA; Unge, P; Wikman, O1
Chung, HH; Kang, SB; Kim, SC; Kim, YH; Kim, YT1
Nguyen, TV1
Bencaiova, G; Breymann, C; Krafft, A1
Bruguera, J; Cladellas, M; Comín-Colet, J; Rizzo, M; Ruiz, S; Torres, A1
Cooper, B; Healy, H; Irish, AB; Kark, A; Kent, AB; Kerr, PG; McMahon, LP; Roger, SD1
Dangsuwan, P; Manchana, T1
Alonso, E; Canser, E; Gilsanz, F; Gredilla, E; Martínez Serrano, B; Pérez-Ferrer, A1
Chen, HH; Chen, YC; Chuang, CK; Lee, KF; Lin, HC; Wu, CJ1
Fernández-Gallego, J; Martín, MA; Sujan, S; Vega, E1
Hojs, N; Malovrh, M; Premru, V1
Benítez, PC; Cabello, LM; Chofles, LC; Lázaro, PS; Serrano-Trenas, JA; Ugalde, PF1
Breymann, C; Krafft, A1
Kim, S; Lee, SC; Lim, H; Yoon, J1
Atalay, H; Guney, I; Kaya, E; Solak, Y; Turk, S; Turkmen, K1
Bisbe, E; Díez-Lobo, AI; García-Erce, JA; Muñoz, M1
Cordero, J; Muñoz, M; Naveira, E; Seara, J1
Gollapudi, S; Hassanzadeh, T; Ichii, H; Masuda, Y; Saffarian, M; Vaziri, ND1
Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J1
Bradbury, BD; Brookhart, MA; Freburger, JK; Kshirsagar, AV; Ng, LJ1
Christoph, P; De Tejada, BM; Irion, O; Schuller, C; Studer, H; Surbek, D1
Chen, J; Chen, X; Cheng, M; Peng, Y; Yang, L; Yin, L1
Benmaadi, A; Bounhiol, C; Cohen, Y; Couprie, R; Dahan, H; Drahi, G; Griuncelli, M; Janklewicz, P; Loridon, C; Machado, G; Rostoker, G; Roy, M1
Devasenapathy, N; Neogi, SB; Zodpey, S1
Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A2
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sörensen, J; Tolmachev, V1
Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR1
Blum, M; Iaina, A; Keren, G; Schwartz, D; Sheps, D; Silverberg, DS; Wexler, D1
Cohen, G; Deicher, R; Hörl, WH; Müllner, M; Ziai, F1
DESHMUKH, PL1
ASSALI, NS; NICHOLSON, DB2
HAGEN, A; LARSEN, V; LASSEN, N1
DEVOE, RW; MOSES, LE1
GARRISON, FE; HOBSON, JB; ITOGA, T; JONES, OW; LASZLO, J1
Bugat, R; Mourey, L; Séronie-Vivien, S; Tohfe, M1
Avram, MM; Blaustein, DA; Chattopadhyay, J; Daoui, R; Gadh, R; Schwenk, MH; Singh, H1
BENSLEY, EH; CAMERON, DG; GRAYSTON, V; WOOD, P1
STRAHM, A; WALTER, F1
HOLLY, RG1
Blum, M; Iaina, A; Schwartz, D; Silverberg, D; Wexler, D1
Almer, S; Bodemar, G; Danielson, BG; Kechagias, S1
Aronoff, GR; Bennett, WM; Blumenthal, S; Charytan, C; Pennell, JP; Reed, J; Rothstein, M; Strom, J; Van Wyck, D; Wolfe, A; Yee, J1
Blaustein, DA; Schwenk, MH1
Cuenca Espiérrez, J; García Erce, JA; Martínez Martín, AA; Modrego Aranda, FJ; Solano, VM1
MEGASSINI, VE; MHANI, NO1
Cuenca, J; García-Erce, JA; Martínez, AA; Molina, J; Muñoz, M; Solano, VM1
Erturk, S; Keven, K; Kutlay, S; Nergizoglu, G1
Durandy, Y; Hulin, S1
Barut, Y; Eres, M; Gürsu, RU; Murat, B; Ozdemir, A; Selamet, U; Yalinbaş, B1
Hörl, WH; Sengölge, G; Sunder-Plassmann, G1
Födinger, M; Hörl, WH; Mittermayer, F; Puttinger, H; Schaller, G; Scheiber-Mojdehkar, B; Sunder-Plassmann, G; Vychytil, A; Wolzt, M1
Martinez, CO; Mazey, RM; McMurray, S; Roppolo, M; Van Wyck, DB1
Ghannam, M; Karkouti, K; McCluskey, SA; Quirt, I; Salpeter, MJ; Yau, TM1
Anbu, AT; Bradbury, MG; Kemp, T; O'donnell, K; Smith, PA1
Cuenca, J; García-Erce, JA; Muñoz, M; Naveira, E; Palmer, JH; Seara, J1
Canser, E; Gilsanz, F; Gimeno, M; Gredilla, E; Martínez, B; Pérez Ferrer, A1
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L1
Bartlett, FR; Bolger, AP; Chapman, CM; Kaprielian, R; O'Leary, J; Penston, HS; Pollock, N1
Cardona, R; Cuenca, J; García-Erce, JA; Martínez, F; Muñoz, M; Pérez-Serrano, L1
Gershanovich, ML; Livshits, ME; Makhnova, EV1
Cho, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, SW; Kim, YT; Nahm, EJ; Yoon, BS1
Cuenca Espiérrez, J; García-Erce, JA; Gómez Barrera, M; Izuel Rami, M; Rabanaque Hernández, MJ; Villar Fernández, I1
Camps, J; Ferré, N; Joven, J; Mackness, B; Mackness, M; Marcas, L; Marsillach, J; Martínez-Vea, A1
Deveci, M; Oymak, O; Sari, I; Sav, T; Sipahioglu, MH; Tokgoz, B; Utas, C1
Auerbach, M; Rodgers, GM1
Martinez, A; Thomas, J1
SLACK, HG; WILKINSON, JF1
Li, H; Wang, SX1
Fujita, I; Hara, K; Hirota, M; Ito, N; Nagasawa, M; Nakatomi, M; Nasu, M; Saito, A; Shigeno, Y; Tanaka, H; Yamaguchi, K1
Fukaya, S; Imamura, T; Iwamoto, T; Kanou, H; Konjiki, O; Takasaki, M1
Irimajiri, S; Matsuoka, Y; Ohoike, H; Suzuki, A1
Fehr, J; Höchli, P; Wagenhäuser, FJ1
Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S1
Mercuriali, F1
Tryba, M1
Blum, M; Iaina, A; Kaplan, E; Peer, G; Silverberg, DS1
Cazzola, M1
Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A1
Bernière, J; Dehullu, JP; Gall, O; Murat, I1
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sundin, J; Tolmachev, V; Valind, S1
Chang, HY; Chen, KS; Kao, HH; Lee, CC; Tsai, CJ1
Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T1
Gottschalk, R; Kaltwasser, JP; Kessler, U; Möller, B; Stucki, G1
Gosriwatana, I; Hider, RC; Kersting, S; Kooistra, MP; Lu, S; Marx, JJ; Nijhoff-Schutte, J1
Eran, A; Harmankaya, O1
Glassman, E1
Casciani, CU; Di Nucci, G; Elia, L; Mandelli, F; Mariani, G; Meloni, C; Piazza, A; Taccone-Gallucci, M; Torromeo, C; Valeri, M1

Reviews

5 review(s) available for glucaric acid and Anemia

ArticleYear
Intravenous iron in oncology.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:6

    Topics: Anemia; Antineoplastic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Neoplasms

2008
[Blood conservation approaches in orthopedic surgery].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2008, Volume: 15, Issue:5

    Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction

2008
Is intravenous iron sucrose the treatment of choice for pregnant anemic women?
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:3

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome

2013
Intravenous iron therapy: well-tolerated, yet not harmless.
    European journal of clinical investigation, 2005, Volume: 35 Suppl 3

    Topics: Anemia; Cytokines; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Neutrophils

2005
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome

1996

Trials

45 trial(s) available for glucaric acid and Anemia

ArticleYear
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
    The Lancet. Haematology, 2018, Volume: 5, Issue:7

    Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Risk Factors; Treatment Outcome; Young Adult

2018
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
    American journal of hematology, 2013, Volume: 88, Issue:12

    Topics: Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Darbepoetin alfa; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Quality of Life; Transferrin; Transplantation Conditioning; Transplantation, Autologous

2013
The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.
    Trials, 2013, Sep-09, Volume: 14

    Topics: Aged; Anemia; Biomarkers; Clinical Protocols; Drug Administration Schedule; England; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Fracture Fixation; Glucaric Acid; Hematinics; Hemoglobins; Hip Fractures; Hospitals, University; Humans; Infusions, Intravenous; Pilot Projects; Postoperative Hemorrhage; Research Design; Reticulocyte Count; Time Factors; Treatment Outcome

2013
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.
    Gynecologic oncology, 2013, Volume: 131, Issue:3

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Genital Neoplasms, Female; Glucaric Acid; Hematinics; Hemoglobins; Humans; Middle Aged; Paclitaxel

2013
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
    Critical care medicine, 2014, Volume: 42, Issue:9

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; APACHE; Critical Illness; Erythrocyte Transfusion; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male; Middle Aged; Protoporphyrins; Single-Blind Method; Transferrin; Trauma Centers; Young Adult

2014
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.
    Blood cells, molecules & diseases, 2014, Volume: 53, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Cognition; Drug Administration Schedule; Exercise Test; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Male; Psychological Tests; Quality of Life; Walking

2014
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
    American journal of hematology, 2015, Volume: 90, Issue:7

    Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous

2015
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.
    Trials, 2016, Apr-12, Volume: 17

    Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Clinical Protocols; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematopoiesis; Hemoglobins; Humans; Middle Aged; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult

2016
A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
    Acta obstetricia et gynecologica Scandinavica, 2008, Volume: 87, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Postpartum Period; Prospective Studies; Quality of Life; Sucrose

2008
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:7

    Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Sweden; Treatment Outcome

2009
Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
    Acta haematologica, 2009, Volume: 121, Issue:1

    Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Menorrhagia; Middle Aged; Preoperative Care; Prospective Studies

2009
Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
    Fetal diagnosis and therapy, 2009, Volume: 25, Issue:2

    Topics: Adult; Anemia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Pregnancy; Recombinant Proteins; Treatment Outcome

2009
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:3

    Topics: Administration, Oral; Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Severity of Illness Index

2010
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
    Gynecologic oncology, 2010, Volume: 116, Issue:3

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Taxoids; Young Adult

2010
Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
    Nephrology (Carlton, Vic.), 2010, Volume: 15, Issue:1

    Topics: Anemia; Chlorides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Renal Dialysis

2010
Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial.
    Transfusion, 2011, Volume: 51, Issue:1

    Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intraventricular; Male; Perioperative Period; Postoperative Complications

2011
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:2

    Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome

2011
Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty.
    British journal of anaesthesia, 2012, Volume: 108, Issue:3

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Postoperative Care

2012
[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2012, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Young Adult

2012
Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Cross-Sectional Studies; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Liver; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Renal Dialysis

2012
Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
    The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Renal Insufficiency; Severity of Illness Index; Time Factors

2003
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.
    Kidney international, 2003, Volume: 64, Issue:2

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Neutrophils; Peritoneal Dialysis; Phagocytosis; Prospective Studies; Respiratory Burst

2003
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease.
    Kidney international. Supplement, 2003, Issue:87

    Topics: Aged; Anemia; Blood Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Transferrin; Treatment Outcome

2003
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
    Kidney international, 2004, Volume: 66, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sepsis

2004
[Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy].
    Annales francaises d'anesthesie et de reanimation, 2005, Volume: 24, Issue:10

    Topics: Anemia; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemodilution; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Postoperative Complications; Reticulocyte Count; Sucrose

2005
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
    Kidney international, 2005, Volume: 68, Issue:6

    Topics: Adult; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Forearm; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Prospective Studies; Regional Blood Flow; Vasodilation

2005
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.
    Kidney international, 2005, Volume: 68, Issue:6

    Topics: Administration, Oral; Aged; Anemia; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Patient Compliance; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome

2005
Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2006, Volume: 53, Issue:1

    Topics: Analysis of Variance; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Postoperative Care; Recombinant Proteins; Time Factors; Treatment Outcome

2006
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study.
    Transfusion medicine (Oxford, England), 2006, Volume: 16, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Male; Pilot Projects; Retrospective Studies

2006
[Postpartum and early postoperative anemia after gynecological surgery: treatment with intravenous iron].
    Revista espanola de anestesiologia y reanimacion, 2006, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Prospective Studies; Puerperal Disorders; Sucrose

2006
Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
    Journal of the American College of Cardiology, 2006, Sep-19, Volume: 48, Issue:6

    Topics: Aged; Anemia; Cardiac Output, Low; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Physical Endurance; Prospective Studies; Transferrin; Walking

2006
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
    Transfusion medicine (Oxford, England), 2006, Volume: 16, Issue:5

    Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood Loss, Surgical; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Receptors, Transferrin; Recombinant Proteins; Reticulocyte Count; Treatment Outcome

2006
Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
    Gynecologic oncology, 2007, Volume: 105, Issue:1

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Middle Aged; Prospective Studies; Uterine Cervical Neoplasms

2007
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:4

    Topics: Aged; Anemia; Antibodies; Aryldialkylphosphatase; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Treatment Outcome

2007
Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    Renal failure, 2007, Volume: 29, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intra-Arterial; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged

2007
Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Blood purification, 2008, Volume: 26, Issue:2

    Topics: Adult; Aged; Anemia; China; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Treatment Outcome

2008
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome

1996
Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
    Seminars in hematology, 1996, Volume: 33, Issue:2 Suppl 2

    Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Reticulocyte Count; Sex Characteristics; Treatment Outcome

1996
Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Nephron, 1996, Volume: 72, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Combinations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Renal Dialysis

1996
The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1997, Volume: 13

    Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin

1997
Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
    Chang Gung medical journal, 2000, Volume: 23, Issue:10

    Topics: Anemia; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Middle Aged; Recombinant Proteins; Renal Dialysis; Uremia

2000
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Clinical nephrology, 2001, Volume: 55, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose

2001
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
    The Journal of rheumatology, 2001, Volume: 28, Issue:11

    Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Disability Evaluation; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Status; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Severity of Illness Index; Treatment Outcome

2001
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
    European journal of clinical investigation, 2002, Volume: 32 Suppl 1

    Topics: Anemia; Dialysis Solutions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Protein Binding; Renal Dialysis; Transferrin

2002
Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
    Renal failure, 2002, Volume: 24, Issue:2

    Topics: Aged; Anemia; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis

2002

Other Studies

75 other study(ies) available for glucaric acid and Anemia

ArticleYear
Intravenous iron for critically ill children. Comparison of three dose regimens.
    Pediatric blood & cancer, 2024, Volume: 71, Issue:1

    Topics: Anemia; Anemia, Iron-Deficiency; Child; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron; Prospective Studies

2024
Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
    Annals of palliative medicine, 2021, Volume: 10, Issue:2

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hospitalization; Humans; Iron; Liver Diseases

2021
A Toddler With Severe Anemia, Pica, and Extremity Swelling.
    Journal of emergency nursing, 2017, Volume: 43, Issue:6

    Topics: Anemia; Blood Transfusion; Edema; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Foot; Glucaric Acid; Hematinics; Humans; Infant; Male; Oxygen Inhalation Therapy; Pica

2017
Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
    Transfusion, 2017, Volume: 57, Issue:10

    Topics: Anemia; Animals; Disease Models, Animal; Dogs; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron; Lung Injury; Mortality; Pneumonia, Bacterial; Pneumonia, Staphylococcal

2017
Zinc deficiency anaemia in haemodialysis patients: Often overlooked but a treatable cause of anaemia.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:12

    Topics: Aged, 80 and over; Anemia; Biomarkers; Carnosine; Darbepoetin alfa; Deficiency Diseases; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Organometallic Compounds; Renal Dialysis; Treatment Outcome; Zinc; Zinc Compounds

2017
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Transfusion; Feasibility Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome

2013
Use of intravenous iron sucrose for treatment of anaemia in pregnancy.
    The Indian journal of medical research, 2013, Volume: 138

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic

2013
Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy.
    The Indian journal of medical research, 2013, Volume: 138

    Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies

2013
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2013, Volume: 67, Issue:5

    Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose

2013
Anemia in the critically ill: do we need to live with it?*.
    Critical care medicine, 2014, Volume: 42, Issue:9

    Topics: Anemia; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male

2014
Assessment of the introduction of a blood management program in orthopaedic surgery.
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:8

    Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Banks; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Hospitals, University; Humans; Length of Stay; Male; Middle Aged; Operative Blood Salvage; Orthopedics; Postoperative Hemorrhage; Program Evaluation; Retrospective Studies; Spain; Tranexamic Acid

2015
Hepcidin as a target of therapy in the treatment of anemia after trauma.
    Critical care medicine, 2015, Volume: 43, Issue:1

    Topics: Anemia; Critical Illness; Female; Ferric Compounds; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male

2015
The author replies.
    Critical care medicine, 2015, Volume: 43, Issue:1

    Topics: Anemia; Critical Illness; Female; Ferric Compounds; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male

2015
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
    The American surgeon, 2015, Volume: 81, Issue:6

    Topics: Aged; Anemia; Aortic Aneurysm, Abdominal; Blood Loss, Surgical; Critical Illness; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Compounds; Jehovah's Witnesses; Male; Recombinant Proteins; Salvage Therapy

2015
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015, Volume: 30, Issue:12

    Topics: Administration, Intravenous; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Stroke; United States

2015
Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
    Critical care medicine, 2016, Volume: 44, Issue:3

    Topics: Adult; Aged; Anemia; Antioxidants; Area Under Curve; C-Reactive Protein; Case-Control Studies; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Healthy Volunteers; Humans; Infusions, Intravenous; Interleukin-6; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress

2016
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Aged; Anemia; Darbepoetin alfa; Disease Management; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Renal Dialysis; Retrospective Studies

2016
Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
    International journal of cardiology, 2016, Jun-01, Volume: 212

    Topics: Anemia; Animals; Cardiotonic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fibrosis; Glucaric Acid; Inflammation; Infusions, Intravenous; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine; Ventricular Remodeling

2016
[Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Terapevticheskii arkhiv, 2016, Volume: 88, Issue:6

    Topics: Adult; Anemia; Biomarkers; Disease Progression; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glucuronidase; Hematinics; Hemoglobins; Humans; Iron; Klotho Proteins; Male; Middle Aged; Outcome Assessment, Health Care; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index

2016
Is there any role of intravenous iron for the treatment of anemia in cancer?
    BMC cancer, 2016, 08-20, Volume: 16, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome

2016
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3

    Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies

2017
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 69, Issue:6

    Topics: Administration, Intravenous; Aged; Anemia; Cardiovascular Diseases; Cause of Death; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Proportional Hazards Models; Renal Dialysis; Retrospective Studies

2017
Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery.
    Anesthesiology, 2008, Volume: 109, Issue:1

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Orthopedic Procedures; Preoperative Care

2008
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    BMC nephrology, 2009, Feb-26, Volume: 10

    Topics: Adult; Aged; Anemia; Comorbidity; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Survival Analysis; Transferrin

2009
Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Jun-15, Volume: 66, Issue:12

    Topics: Adult; Anemia; Cohort Studies; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Renal Dialysis; Retrospective Studies; Transferrin

2009
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical ou
    Journal of cardiac failure, 2009, Volume: 15, Issue:9

    Topics: Aged; Aged, 80 and over; Anemia; Chronic Disease; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Neurotransmitter Agents; Pilot Projects; Prospective Studies; Recombinant Proteins; Survival Rate; Syndrome; Time Factors; Treatment Outcome

2009
[Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases].
    Revista espanola de anestesiologia y reanimacion, 2009, Volume: 56, Issue:10

    Topics: Adult; Anemia; Anti-Anxiety Agents; Anticoagulants; Cervix Uteri; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Dalteparin; Embolization, Therapeutic; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immobilization; Jehovah's Witnesses; Menorrhagia; Oxygen Inhalation Therapy; Parenteral Nutrition; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Thromboembolism; Treatment Refusal; Young Adult

2009
[Treatment with intravenous iron and ferritin level].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:3

    Topics: Anemia; Blood Proteins; Case-Control Studies; Clinical Protocols; Drug Monitoring; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Oxidation-Reduction; Prospective Studies; Renal Dialysis

2010
The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents.
    Artificial organs, 2011, Volume: 35, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis

2011
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
    The Korean journal of internal medicine, 2010, Volume: 25, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans

2010
Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
    Renal failure, 2011, Volume: 33, Issue:3

    Topics: Adult; Aged; Anemia; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis

2011
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
    British journal of anaesthesia, 2011, Volume: 107, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Costs and Cost Analysis; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Preoperative Care

2011
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.
    American journal of nephrology, 2012, Volume: 36, Issue:1

    Topics: Adult; Anemia; Apoptosis; Carbohydrates; Escherichia coli; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Neutrophils; Phagocytosis; Staphylococcus aureus; Time Factors

2012
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
    The American journal of cardiology, 2012, Oct-01, Volume: 110, Issue:7

    Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome

2012
Changing patterns of anemia management in US hemodialysis patients.
    The American journal of medicine, 2012, Volume: 125, Issue:9

    Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron Compounds; Kidney Failure, Chronic; Male; Middle Aged; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; United States

2012
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
    Journal of perinatal medicine, 2012, May-13, Volume: 40, Issue:5

    Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Young Adult

2012
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
    Clinical nephrology, 2002, Volume: 58 Suppl 1

    Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Oxygen Consumption; Recombinant Proteins; Stroke Volume

2002
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
    British journal of haematology, 2003, Volume: 120, Issue:5

    Topics: Adult; Aged; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron Radioisotopes; Liver; Male; Middle Aged; Reticulocyte Count; Spleen; Tomography, Emission-Computed

2003
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose

2003
Intravenous iron therapy with saccharated iron oxide.
    The Indian medical gazette, 1952, Volume: 87, Issue:7

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds

1952
[Hematological response of pregnant to saccharated iron oxide].
    El Dia medico, 1952, Aug-28, Volume: 24, Issue:55

    Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds; Pregnancy; Pregnancy Complications

1952
[Hemoglobin level in normal pregnancy after injection of colloidal iron saccharate].
    Nordisk medicin, 1954, Apr-29, Volume: 51, Issue:18

    Topics: Anemia; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Iron; Pregnancy

1954
Iron therapy in pregnancy; a comparative study of various modes.
    California medicine, 1954, Volume: 81, Issue:5

    Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications

1954
Infusion of saccharated iron oxide in the treatment of iron deficiency anemia.
    North Carolina medical journal, 1962, Volume: 23

    Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; North Carolina

1962
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
    Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:3

    Topics: Anemia; Chronic Disease; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Radiation Injuries; Recombinant Proteins; Reticulocyte Count

2003
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
    Canadian Medical Association journal, 1951, Volume: 64, Issue:1

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1951
[Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
    Zentralblatt fur Gynakologie, 1951, Volume: 73, Issue:11

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron

1951
Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
    Blood, 1951, Volume: 6, Issue:11

    Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron; Obstetrics; Pregnancy

1951
The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
    Surgery, gynecology & obstetrics, 1952, Volume: 94, Issue:5

    Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds; Pregnancy

1952
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:4

    Topics: Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Nandrolone; Nandrolone Decanoate; Sucrose

2004
Treatment of anaemia in inflammatory bowel disease with iron sucrose.
    Scandinavian journal of gastroenterology, 2004, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Retrospective Studies; Sucrose; Treatment Outcome

2004
Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.
    Clinical nephrology, 2004, Volume: 62, Issue:2

    Topics: Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron Deficiencies; Jehovah's Witnesses; Kidney Diseases; Middle Aged; Severity of Illness Index; Time Factors

2004
[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].
    Medicina clinica, 2004, Sep-11, Volume: 123, Issue:8

    Topics: Aged; Aged, 80 and over; Anemia; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Iron; Male; Sucrose

2004
[Cooley's syndrome in the adult: treatment with intravenous iron saccharate].
    La Semana medica, 1950, May-04, Volume: 57, Issue:18

    Topics: Adult; Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron

1950
Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
    Archives of orthopaedic and trauma surgery, 2005, Volume: 125, Issue:5

    Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Prospective Studies

2005
Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients.
    Kidney international, 2005, Volume: 68, Issue:1

    Topics: Anemia; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis

2005
Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
    Nephrology (Carlton, Vic.), 2005, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver; Male; Middle Aged; Renal Dialysis; Retrospective Studies

2005
Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
    Acta paediatrica (Oslo, Norway : 1992), 2005, Volume: 94, Issue:12

    Topics: Anemia; Child; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Prospective Studies; Recombinant Proteins

2005
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
    European journal of heart failure, 2006, Volume: 8, Issue:5

    Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines

2006
[Use of Venofer in management of anemia in cancer patients].
    Voprosy onkologii, 2006, Volume: 52, Issue:5

    Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome

2006
[Budget impact analysis of a blood saving program for urgent traumatological surgery].
    Medicina clinica, 2007, Jan-13, Volume: 128, Issue:1

    Topics: Administration, Oral; Age Factors; Aged, 80 and over; Anemia; Budgets; Confidence Intervals; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Iron; Length of Stay; Male; Recombinant Proteins

2007
Intravenous iron.
    The New England journal of medicine, 2007, Jul-05, Volume: 357, Issue:1

    Topics: Anemia; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Molecular Weight; Renal Dialysis; United States; United States Food and Drug Administration

2007
Blood conservation in the critically ill.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Aug-15, Volume: 64, Issue:16 Suppl 1

    Topics: Adult; Aged; Anemia; Baltimore; Blood; Blood Chemical Analysis; Clinical Protocols; Critical Care; Critical Illness; Drug Costs; Drug Monitoring; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pilot Projects; Recombinant Proteins

2007
Intravenous treatment of anaemia with an iron-sucrose preparation.
    Lancet (London, England), 1949, Jan-01, Volume: 1, Issue:6540

    Topics: Anemia; Anemia, Sickle Cell; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Sucrose

1949
[A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1982, Volume: 56, Issue:3

    Topics: Anemia; Culture Media; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Legionella

1982
[A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1994, Volume: 31, Issue:10

    Topics: Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous

1994
Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
    American journal of hematology, 1993, Volume: 43, Issue:1

    Topics: Adult; Anemia; Duodenal Ulcer; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iatrogenic Disease; Malabsorption Syndromes; Middle Aged; Osteomalacia

1993
Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
    European journal of haematology, 1993, Volume: 51, Issue:1

    Topics: Anemia; Arthritis, Rheumatoid; C-Reactive Protein; Drug Administration Schedule; Erythrocyte Count; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Time Factors

1993
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors

1996
Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
    The Journal of laboratory and clinical medicine, 1997, Volume: 130, Issue:4

    Topics: Anemia; Arthritis, Rheumatoid; Blood Donors; Blood Transfusion, Autologous; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Recombinant Proteins

1997
[Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents].
    Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 1998, Volume: 84, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Anemia; Blood Loss, Surgical; Child; Child, Preschool; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Postoperative Complications; Spinal Fusion; Sucrose

1998
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
    British journal of haematology, 1999, Volume: 104, Issue:2

    Topics: Adult; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Male; Middle Aged; Sucrose; Tomography, Emission-Computed; Transferrin

1999
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2001, Volume: 21 Suppl 3

    Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose

2001
Oral iron therapy with ferrous fumarate and polysaccharide iron complex.
    ANNA journal, 1992, Volume: 19, Issue:3

    Topics: Administration, Oral; Anemia; Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Kidney Diseases; Renal Dialysis

1992
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.
    American journal of nephrology, 1987, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Alleles; Anemia; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemochromatosis; Humans; Male; Renal Dialysis; Risk; Transfusion Reaction; Uremia

1987